Clinical TrialsSearch results
Number of results: 691
Recruiting
- A double-blind, placebo-controlled, randomized, dose-escalating, multicenter, Phase 1 study to assess the safety and tolerability of ART-123 in combination with leucovorin/5-fluorouracil/oxaliplatin and bevacizumab in metastatic colorectal cancer patients
- metastatic colorectal cancer
- Tawara Shunsuke
- 2022-02-01
Other
- Observational Study of RAS monitoring for RAS/BRAF wild advanced Colorectal Cancer Patients treated with anti EGFR antibody
- colorectal cancer
- Kataoka Kozo
- 2022-01-22
Not yet recruiting
- A prospective study on the efficacy and safety of double stenting with a narrow covered self-expandable metallic stent (SEMS) for malignant distal bile duct stenosis
- obstructive jaundice
- Shiomi Hideyuki
- 2022-01-22
Recruiting
- Investigation of optimal first-line technique of endovascular therapy for acute ischemic stroke
- Acute ischemic stroke
- Toyoda Kazunori
- 2022-01-22
Other
- A Phase 3 Study to Compare the Immunogenicity against COVID-19, of S-268019 to the ChAdOx1 nCoV-19 vaccine (COVID-19)
- Prevention of COVID-19
- Nagata Tsutae
- 2022-01-13
Recruiting
- FUTURE study
- Unruptured cerebral aneurysm
- Imamura Hirotoshi
- 2022-01-07
Recruiting
- A Randomized Controlled Trial of the Preventive Effect of Haptoglobin Administration on Hemolysis-Related Organ Damage in Patients undergoing Cardiovascular Surgery
- Valvular heart disease,aortic aneurysm,aortic dissection,coronary artery disease
- Hokka Mai
- 2022-01-05
Recruiting
- Efficacy of therapeutic intervention with vedolizumab for ulcerative colitis patients with no or mild symptom and uncontrolled endoscopic activity: A multicenter- non-randomized trial
- ulcerative colitis
- ooi makoto
- 2021-12-28
Completed
- A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151(rhPTX-2) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
- Idiopathic pulmonary fibrosis
- Shimoda Yukiko
- 2021-12-26
Other
- A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Patients With Duchenne Muscular Dystrophy (EMBARK)
- Duchenne Muscular Dystrophy
- O Malley Patrick
- 2021-12-25